EGFR and cancer: Anoikis resistance, essential for cancer metastasis, is promoted in cancer stem cells (CSCs) by elevated ITGA2 and ITGB1 expression, which interact with EGFR to activate the ERK/Akt survival pathway, enabling CSCs to evade cell death in the absence of extracellular matrix [33].